BSIM2 Biomolecular is a company that provides Amyloidosis, Drug development, Polyneuropathy and more. BSIM2 Biomolecular is headquartered in Portugal Coimbra. BSIM2 Biomolecular was founded in 2011. and was founded by Carlos Simões, Rui Brito. BSIM2 Biomolecular has a total of 12 patents
visualizing technology portfolio of hot application areas and blank areas for BSIM2 Biomolecular
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for BSIM2 Biomolecular
Sign up to view the full data
Free Trial Now
Download
BSIM2 Biomolecular Frequently Asked Questions
What is BSIM2 Biomolecular's industry?
BSIM2 Biomolecular is in the industry of:Pharmaceutical and Medicine ManufacturingResearch and Development in the Physical, Engineering, and Life Sciences
What technical fields has BSIM2 Biomolecular researched?
BSIM’s mission is to deliver quality drug candidates with high capital efficiency against transthyretin-mediated amyloidosis, including clinical manifestations...